{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:10:03Z","timestamp":1776474603606,"version":"3.51.2"},"reference-count":62,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a challenging condition linked to antiresorptive and antiangiogenic medications. Their complex pathophysiology and resistance to standard treatments have led researchers to explore adjunctive therapies. This systematic review evaluated the effectiveness of autologous platelet concentrates\u2014namely platelet-rich plasma (PRP) and platelet-rich fibrin (PRF)\u2014in promoting healing, bone regeneration, and symptom relief in MRONJ patients. Materials and Methods: A systematic literature search was conducted using PubMed, Scopus, and Web of Science for studies that assessed the use of PRP or PRF in MRONJ management. The risk of bias and study quality were evaluated using ROB-2 and ROBINS-I tools. Results: A total of 24 studies were included: seven on PRP and 17 on PRF. Reported complete mucosal healing rates ranged from 33% to 100% for PRP and from 36% to 100% for PRF. Although two randomized controlled trials and one prospective observational study found no statistically significant advantage of PRF over conventional surgical treatments, most studies indicated positive outcomes. Overall, the methodological quality varied, with several studies showing moderate-to-high risk of bias. Conclusions: Platelet concentrates can add benefits to traditional MRONJ treatments. The current evidence suggests that integrating these autologous therapies with conventional approaches clinically enhances healing outcomes, supports bone regeneration, and alleviates symptoms, ultimately leading to improved patient care.<\/jats:p>","DOI":"10.3390\/medicina61081496","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:46:04Z","timestamp":1755787564000},"page":"1496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autologous Platelet Concentrates in the Management of Medication-Related Osteonecrosis of the Jaw: A Systematic Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8746-1634","authenticated-orcid":false,"given":"Filipa","family":"Ferreira","sequence":"first","affiliation":[{"name":"Experimental Biology Unit, Department of Biomedicine, Faculty of Medicine of Porto, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8470-152X","authenticated-orcid":false,"given":"Carlos","family":"Faria","sequence":"additional","affiliation":[{"name":"Department of Surgery and Physiology, Faculty of Medicine of Porto, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2119-4479","authenticated-orcid":false,"given":"Daniel Humberto","family":"Pozza","sequence":"additional","affiliation":[{"name":"Experimental Biology Unit, Department of Biomedicine, Faculty of Medicine of Porto, University of Porto, 4200-319 Porto, Portugal"},{"name":"Institute for Research and Innovation in Health-i3S, University of Porto, 4200-135 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0035-1558452","article-title":"\u201cPhossy Jaw\u201d and \u201cBis-phossy Jaw\u201d of the 19th and the 21st Centuries: The Diuturnity of John Walker and the Friction Match","volume":"8","author":"Pollock","year":"2015","journal-title":"Craniomaxillofac. Trauma Reconstr."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lon\u010dar Brzak, B., Horvat Aleksijevi\u0107, L., Vindi\u0161, E., Kordi\u0107, I., Grani\u0107, M., Vidovi\u0107 Juras, D., and Andabak Rogulj, A. (2023). Osteonecrosis of the Jaw. Dent. J., 11.","DOI":"10.3390\/dj11010023"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","article-title":"Osteonecrosis of the jaws associated with cancer chemotherapy","volume":"61","author":"Wang","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.oooo.2021.03.006","article-title":"Quality of life in patients affected by medication-related osteonecrosis of the jaws: A systematic review","volume":"132","author":"Bensi","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Calabria, E., Antonelli, A., Barone, S., Adamo, D., Salviati, M., Cerra, M.G., Bennardo, F., and Giudice, A. (2023). Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case-Control Pilot Study. Dent. J., 11.","DOI":"10.3390\/dj11060147"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Vescovi, P., De Francesco, P., Giovannacci, I., Le\u00e3o, J.C., and Barone, A. (2024). Piezoelectric Surgery, Er: YAG Laser Surgery and Nd:YAG Laser Photobiomodulation: A Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws (MRONJ). Dent. J., 12.","DOI":"10.3390\/dj12080261"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hanna, R., Miron, I.C., Dalvi, S., Arany, P., Bensadoun, R.J., and Benedicenti, S. (2024). A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials. Pharmaceuticals, 17.","DOI":"10.3390\/ph17081011"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","article-title":"Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases","volume":"69","author":"Otto","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management from the International Task Force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"J. Clin. Densitom."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/SCS.0b013e3182869968","article-title":"Cell therapy in bisphosphonate-related osteonecrosis of the jaw","volume":"24","author":"Villanueva","year":"2013","journal-title":"J. Craniofac. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/02683555241256543","article-title":"Treatment of vascular leg ulcers with leukocyte- and platelet-rich fibrin (L-PRF): A systematic review","volume":"39","author":"Dorpmans","year":"2024","journal-title":"Phlebology"},{"key":"ref_14","first-page":"e62198","article-title":"Effectiveness of Injectable Platelet-Rich Fibrin Therapy in Alopecia and Facial Rejuvenation: A Systematic Review","volume":"16","author":"Mohale","year":"2024","journal-title":"Cureus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.oooo.2021.05.013","article-title":"Autologous platelet concentrates in oral surgery: Protocols, properties, and clinical applications","volume":"133","year":"2022","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00784-024-05641-2","article-title":"Use of platelet- and leukocyte-rich fibrin (L-PRF) as a healing agent in the postoperative period of third molar removal surgeries: A systematic review","volume":"28","author":"Ribeiro","year":"2024","journal-title":"Clin. Oral Investig."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Steller, D., Herbst, N., Pries, R., Juhl, D., and Hakim, S.G. (2019). Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-43798-z"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tibtech.2008.11.009","article-title":"Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)","volume":"27","author":"Rasmusson","year":"2009","journal-title":"Trends Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/prd.12550","article-title":"Differences between first- and second-generation autologous platelet concentrates","volume":"97","author":"Calciolari","year":"2025","journal-title":"Periodontology 2000"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0972-124X.145821","article-title":"In vitro evaluation of mechanical properties of platelet-rich fibrin membrane and scanning electron microscopic examination of its surface characteristics","volume":"19","author":"Sam","year":"2015","journal-title":"J. Indian Soc. Periodontol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Pereira, V.B.S., Lago, C.A.P., Almeida, R.A.C., Barbirato, D.D.S., and Vasconcelos, B. (2023). Biological and Cellular Properties of Advanced Platelet-Rich Fibrin (A-PRF) Compared to Other Platelet Concentrates: Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25010482"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1902\/jop.2016.160443","article-title":"Optimized Platelet-Rich Fibrin with the Low-Speed Concept: Growth Factor Release, Biocompatibility, and Cellular Response","volume":"88","author":"Miron","year":"2017","journal-title":"J. Periodontol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/jbm.a.36346","article-title":"The in vitro release of cytokines and growth factors from fibrin membranes produced through horizontal centrifugation","volume":"106","author":"Leite","year":"2018","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res. Synth. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"J. Am. Dent. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.joms.2011.02.078","article-title":"Bisphosphonate-related osteonecrosis of the jaws\u2014An initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma","volume":"69","author":"Curi","year":"2011","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: A report of 32 cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","article-title":"Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"41","author":"Knezevic","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/scd.12023","article-title":"Bisphosphonate-related osteonecrosis of the jaws: Analysis of a case series at a dental school","volume":"34","author":"Tucci","year":"2014","journal-title":"Spec. Care Dent."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"298945","DOI":"10.1155\/2014\/298945","article-title":"Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: Personal experience and review of the literature","volume":"2014","author":"Longo","year":"2014","journal-title":"Int. J. Dent."},{"key":"ref_34","first-page":"e684","article-title":"Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement","volume":"26","year":"2021","journal-title":"Med. Oral"},{"key":"ref_35","first-page":"961","article-title":"Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"55","author":"Dinca","year":"2014","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: A prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.4317\/medoral.19458","article-title":"Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: A pilot study comparing fibrin rich in growth factors and teriparatide","volume":"19","author":"Pelaz","year":"2014","journal-title":"Med. Oral"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","article-title":"Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: A prospective study of 15 patients","volume":"45","author":"Norholt","year":"2016","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/SCS.0000000000005475","article-title":"Medication-Related Osteonecrosis of the Jaw: The Use of Leukocyte-Platelet-Rich Fibrin as an Adjunct in the Treatment","volume":"30","author":"Valente","year":"2019","journal-title":"J. Craniofac. Surg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jormas.2019.02.011","article-title":"The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series","volume":"121","author":"Capella","year":"2020","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.joms.2019.12.008","article-title":"The Effect of Platelet-Rich Fibrin Membrane in Surgical Therapy of Medication-Related Osteonecrosis of the Jaw","volume":"78","author":"Szentpeteri","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e13334","DOI":"10.1111\/dth.13334","article-title":"Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw","volume":"33","author":"Bennardo","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5507\/bp.2020.023","article-title":"The use of platelet-rich fibrin in the surgical treatment of medication-related osteonecrosis of the jaw: 40 patients prospective study","volume":"165","author":"Zelinka","year":"2021","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ozalp, O., Yildirimyan, N., Ozturk, C., Kocabalkan, B., Simsek Kaya, G., Sindel, A., and Altay, M.A. (2021). Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin. BMC Oral Health, 21.","DOI":"10.1186\/s12903-021-01965-7"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Blatt, S., Kruger, M., Kammerer, P.W., Thiem, D.G.E., Matheis, P., Eisenbeiss, A.K., Wiltfang, J., Al-Nawas, B., and Naujokat, H. (2022). Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw. J. Clin. Med., 11.","DOI":"10.3390\/jcm11030682"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10006-022-01094-7","article-title":"Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid-case-control study","volume":"27","author":"Parise","year":"2023","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Bouland, C.L., Javadian, R., Gilis, S., Yanni, A., Le Clercq, M., Mestrallet, P., Kampouridis, S., Bron, D., Lalmand, M., and Vanden Eynden, X. (2024). Treatment of medication-related osteonecrosis of the jaw with cell therapy. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1338376"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10006-024-01291-6","article-title":"The adjunctive use of Leukocyte-Platelet Rich Fibrin (L-PRF) in the management of Medication Related Osteonecrosis of the Jaw (MRONJ): A retrospective observational study","volume":"28","author":"Aslam","year":"2024","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.joms.2016.12.005","article-title":"Does the Addition of Bone Morphogenetic Protein 2 to Platelet-Rich Fibrin Improve Healing After Treatment for Medication-Related Osteonecrosis of the Jaw?","volume":"75","author":"Park","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.oooo.2018.06.007","article-title":"Can platelet-rich fibrin improve healing after surgical treatment of medication-related osteonecrosis of the jaw? A pilot study","volume":"126","author":"Giudice","year":"2018","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1007\/s00784-020-03766-8","article-title":"The effect of concentrated growth factor (CGF) in the surgical treatment of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A randomized controlled study","volume":"25","author":"Yuce","year":"2021","journal-title":"Clin. Oral Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: The kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.sdentj.2022.01.003","article-title":"Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies","volume":"34","author":"AlRowis","year":"2022","journal-title":"Saudi Dent. J."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Kuehn, S., Scariot, R., and Elsalanty, M. (2023). Medication-Related Osteonecrosis: Why the Jawbone?. Dent. J., 11.","DOI":"10.3390\/dj11050109"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bennett, B., Tahir, H., Solanki, K., and Ali, N. (2023). An Update on Medication-Related Osteonecrosis of the Jaw in Patients with Osteoporosis. EMJ Rheumatol., 10.","DOI":"10.33590\/emjrheumatol\/10300262"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.oooo.2024.05.014","article-title":"Medication-related osteonecrosis of the jaw (MRONJ) systemic review: Mevalonate pathway mechanisms explored","volume":"138","author":"Cho","year":"2024","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00198-025-07464-7","article-title":"Prognostic indicators in medication-related osteonecrosis of the jaw: A systematic review and meta-analysis","volume":"36","author":"Wei","year":"2025","journal-title":"Osteoporos. Int."},{"key":"ref_58","first-page":"37","article-title":"New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: A 10-year review","volume":"34","author":"Gelpi","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Hwang, S., Jee, H.K., Kim, Y., Yoon, H.-C., Yun, P.-Y., and Ku, J.-K. (2025). Clinical outcome and volumetric 3D analysis of biofluorescence imaging system guided surgery for Medication-Related Osteonecrosis of the Jaw (MRONJ). BMC Oral Health, 25.","DOI":"10.1186\/s12903-025-05484-7"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Garzino Demo, P., Bojino, A., Roccia, F., Malandrino, M.C., Cocis, S., and Ramieri, G. (2021). Different Presentation and Outcomes in the Surgical Treatment of Advanced MRONJ in Oncological and Nononcological Patients Taking or Not Corticosteroid Therapy. Biomed. Res. Int., 2021.","DOI":"10.1155\/2021\/7855497"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kammerhofer, G., Vegh, D., B\u00e1nyai, D., V\u00e9gh, \u00c1., Joob-Fancsaly, A., Hermann, P., Geczi, Z., Hegedus, T., Somogyi, K.S., and Bencze, B. (2023). Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ). J. Clin. Med., 12.","DOI":"10.3390\/jcm12082976"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/09537104.2017.1293812","article-title":"The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane","volume":"29","author":"Pinto","year":"2018","journal-title":"Platelets"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:51Z","timestamp":1760034771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081496"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081496","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}